Search clinical trials for: Phase 2A, safety and efficacy trial with CE-326,597 in patients with T2DM.

Total 493668 results

Pfizer

Completed

A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Weight Management | Treatment Of Obesity

Canada, United States, Bulgaria, Spain, Mexico, India, Puerto Rico
Pfizer

Completed

Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic Gallstones

Obesity

United States
Damanhour University
Tanta University

Recruiting

Empagliflozin Versus Vildagliptin in CAD Patients With T2DM

Coronary Artery Disease | Type 2 Diabetes

Egypt
Rehab Werida

Completed

Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

Diabetes Mellitus, Type 2

Egypt
Fourth People's Hospital of Shenyang

Completed

The Correlation Between the Pulmonary Function and Intrarenal Hemodynamics in 37 T2DM Patients in Early Period

Diabetes Mellitus, Type 2
RenJi Hospital
Ruijin Hospital

Completed

Association of Carbamylated HDL and CAD in T2DM Patients

Type 2 Diabetes Mellitus With Circulatory Complciation

China
Iworks Laser and Vision Center
Ocular Therapeutix, Inc.

Completed

Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL. (DEXTENZA)

Cataract

United States
Pfizer

Completed

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

Diabetes Mellitus, Type 2

Taiwan, United States, Hungary, Canada, Slovakia, India, Bulgaria
Shanghai Jiao Tong University School of Medicine

Recruiting

Chinese Endocrinologists Health Education Study (CREATION)

Type 2 Diabetes

China
Peking University

Active, not recruiting

Risk Factors for Type 2 Diabetes Mellitus With Cognitive Impairment: a Cohort Study

Diabetes Mellitus, Type 2 | Cognitive Dysfunction | Gut Microbiota
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes

T2DM

China
Beijing Dongfang Biotech Co., Ltd.

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Type2 Diabetes Mellitus

China
Beijing Dongfang Biotech Co., Ltd.

Not yet recruiting

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus

China
AstraZeneca
Parexel

Terminated

A Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

United Kingdom
Newsoara Biopharma Co., Ltd.

Recruiting

Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM

T2DM

China
Jaseng Medical Foundation

Completed

Efficacy and Safety of Cortex Eucommiae (CE: Eucommia Ulmoides Oliver Extract) in Subjects With Mild Osteoarthritis

Osteoarthritis

Korea, Republic of
LG Life Sciences

Completed

Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin

T2DM
AstraZeneca

Terminated

A Phase IV Study in Drug-Naive Patients With T2DM in China

Type 2 Diabetes Mellitus

China
Implantica CE Reflux Ltd.

Active, not recruiting

Evaluation of Safety and Effectiveness of the RefluxStop Device in the Management of GERD

GERD

Hungary, Serbia
University of Thessaly

Not yet recruiting

CE-IOUS for Patients With Pancreatic Cancer Undergoing Surgery: A Prospective, Proof-of-concept Trial

Pancreatic Cancer | Liver Metastases
Muğla Sıtkı Koçman University

Completed

Effectiveness of Telehealth Program in Patients With Type 2 Diabetes

Type 2 Diabetes

Turkey
LG Chem

Unknown

Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg

T2DM
Hua Medicine Limited
Tigermed Consulting Co., Ltd

Completed

A Multi-center 12-week Study of HMS5552 in T2DM

Diabetes Mellitus, Type 2

China
Merck Sharp & Dohme LLC

Completed

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Type 2 Diabetes Mellitus
AstraZeneca

Terminated

Randomised Double-Blind, Placebo-Controlled, Parallel Group Study in Patients With Active Rheumatoid Arthritis:Magnetic Resonance Imaging Sub-Study (OSKIRA 4 SS)

Rheumatoid Arthritis

United States, Bulgaria, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Netherlands, Canada, Czech Republic, Poland
Assiut University

Not yet recruiting

CE-MRI&CESM in Solid Breast Lesions

Breast Neoplasms
AstraZeneca
Bristol-Myers Squibb

Completed

An 18 Week Efficacy and Safety Study of Saxagliptin and Metformin XR Combination in Subjects With Type 2 Diabetes (SCORE)

Type 2 Diabetes

United States, Peru, Mexico, Colombia, Costa Rica
Sichuan Haisco Pharmaceutical Group Co., Ltd

Completed

HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Diabetes Mellitus, Type 2

China
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes (SURPASS-3)

Type 2 Diabetes Mellitus

United States, Korea, Republic of, Taiwan, Italy, Austria, Puerto Rico, Hungary, Greece, Poland, Spain, Romania, Ukraine, Argentina
Bota Bio Co., Ltd.

Completed

Phase 2a Study to Evaluate the Safety and Efficacy of PH100 Tablet in T2DM Patients With Recent Cardiovascular (PH100_IIa)

Type 2 Diabetes Mellitus With Circulatory Complciation
Taiwan Resonant Waves Research Corporation

Completed

Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Taiwan
Riphah International University

Completed

Exergaming Versus Aerobic Exercises on Mild Cognitive Impairment

Cognitive Impairment | Type 2 Diabetes

Pakistan
Yanbing Li

Not yet recruiting

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients | Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect | 128 Patients Were Randomly Assigned 1:1 | Metformin and Insulin Glargine Combined... and other conditions

China
AstraZeneca

Completed

AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.

T2DM With NAFLD
Postgraduate Institute of Medical Education and...

Completed

Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus (SCT)

Type 2 Diabetes Mellitus

India
Hospital San Jose Tec de Monterrey
TecSalud; Fundación Santos y de la Garza Evia I.B.P

Recruiting

Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Mexico
MedImmune LLC

Completed

A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Type 2 Diabetes Mellitus

Netherlands, Sweden
Chipscreen Biosciences, Ltd.

Completed

Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

T2DM

China
Copka Sonpashan

Not yet recruiting

The Impact of Different Feeding Modes on Patients With Intracerebral Hemorrhage

Intracerebral Hemorrhage
Copka Sonpashan

Not yet recruiting

Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease

Cerebral Small Vessel Diseases
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls

Type 2 Diabetes Mellitus | Genetic Mutations | Gene Polymorphisms | Susceptibility, Genetic

China
Ahmadu Bello University Teaching Hospital

Not yet recruiting

The Effectiveness of Stellate Ganglion Block in Managing Dysphagia in Patients With Medullary Infarction

Bulbar Palsy
Ivantis, Inc.

Completed

Safety and Efficacy Trial to Evaluate the Hydrus(TM) Implant in Subjects Undergoing Cataract Surgery. (Hydrus II)

Primary Open Angle Glaucoma | Cataract Unilateral Pending Extraction | Glaucoma, Open Angle, Pseudo-exfoliative

Germany, Italy, Netherlands, Spain
Novartis Pharmaceuticals

Completed

Vildagliptin 50 mg Twice Daily in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Type 2 Diabetes Mellitus

Egypt
Yes Skin Medical Group

Not yet recruiting

A Clinical Study to Evaluate the Efficacy and Safety of Monopolar Radiofrequency Combined With SkinCeuticals A.G.E and Skinceuticals CE FERULIC for Improving Facial Skin Elasticity, Tightening and Fading Fine Lines

Skin Aging
IlDong Pharmaceutical Co Ltd

Recruiting

IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics

Type 2 Diabetes

Germany
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus | T2DM

China
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)

Type 2 Diabetes

China, Australia, Korea, Republic of, India
University of Regensburg

Completed

CE-IOUS Impact on Surgical Strategy of Liver Tumours and Liver Metastases

Liver Neoplasms | Surgery | Colorectal Cancer Metastatic | Ultrasound | Metastases | Liver/Hepatobiliary Cancer

Germany
GlaxoSmithKline

Completed

Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM (T2DM)

Diabetes Mellitus

Spain, United Kingdom

3

Subscribe